Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-03-13 | JOHNSON & JOHNSON | Broadhurst Vanessa
(EVP, Global Corp Affairs) |
S | Common Stock | D | 8891 | $162.16 - $162.16 | $1,441,764 |
| 2024-02-13 | JOHNSON & JOHNSON | Wengel Kathryn E
(EVP, Chief TO and Risk Officer) |
M | Common Stock | A | 651 | $0.00 - $0.00 | $0 |
| 2024-02-13 | JOHNSON & JOHNSON | Wengel Kathryn E
(EVP, Chief TO and Risk Officer) |
F | Common Stock | D | 333 | $157.85 - $157.85 | $52,564 |
| 2024-02-13 | JOHNSON & JOHNSON | Wolk Joseph J
(Exec VP, CFO) |
M | Common Stock | A | 1780 | $0.00 - $0.00 | $0 |
| 2024-02-13 | JOHNSON & JOHNSON | Wolk Joseph J
(Exec VP, CFO) |
F | Common Stock | D | 773 | $157.85 - $157.85 | $122,018 |
| 2024-02-13 | JOHNSON & JOHNSON | Taubert Jennifer L
(EVP, WWC. Innovative Medicine) |
M | Common Stock | A | 1302 | $0.00 - $0.00 | $0 |
| 2024-02-13 | JOHNSON & JOHNSON | Taubert Jennifer L
(EVP, WWC. Innovative Medicine) |
F | Common Stock | D | 666 | $157.85 - $157.85 | $105,128 |
| 2024-02-13 | JOHNSON & JOHNSON | Swanson James D.
(EVP, CIO) |
M | Common Stock | A | 447 | $0.00 - $0.00 | $0 |
| 2024-02-13 | JOHNSON & JOHNSON | Swanson James D.
(EVP, CIO) |
F | Common Stock | D | 195 | $157.85 - $157.85 | $30,780 |
| 2024-02-13 | JOHNSON & JOHNSON | Schmid Timothy
(EVP, WW Chair, MedTech) |
M | Common Stock | A | 499 | $0.00 - $0.00 | $0 |
| 2024-02-13 | JOHNSON & JOHNSON | Schmid Timothy
(EVP, WW Chair, MedTech) |
F | Common Stock | D | 250 | $157.85 - $157.85 | $39,462 |
| 2024-02-13 | JOHNSON & JOHNSON | Fasolo Peter
(Exec VP, Chief HR Officer) |
M | Common Stock | A | 925 | $0.00 - $0.00 | $0 |
| 2024-02-13 | JOHNSON & JOHNSON | Fasolo Peter
(Exec VP, Chief HR Officer) |
F | Common Stock | D | 474 | $157.85 - $157.85 | $74,820 |
| 2024-02-13 | JOHNSON & JOHNSON | Hait William
(See Remarks) |
M | Common Stock | A | 834 | $0.00 - $0.00 | $0 |
| 2024-02-13 | JOHNSON & JOHNSON | Hait William
(See Remarks) |
F | Common Stock | D | 427 | $157.85 - $157.85 | $67,401 |
| 2024-02-13 | JOHNSON & JOHNSON | Duato Joaquin
(CEO and Chairman of the Board) |
M | Common Stock | A | 3470 | $0.00 - $0.00 | $0 |
| 2024-02-13 | JOHNSON & JOHNSON | Duato Joaquin
(CEO and Chairman of the Board) |
F | Common Stock | D | 1507 | $157.85 - $157.85 | $237,879 |
| 2024-02-13 | JOHNSON & JOHNSON | Broadhurst Vanessa
(EVP, Global Corp Affairs) |
M | Common Stock | A | 408 | $0.00 - $0.00 | $0 |
| 2024-02-13 | JOHNSON & JOHNSON | Broadhurst Vanessa
(EVP, Global Corp Affairs) |
F | Common Stock | D | 209 | $157.85 - $157.85 | $32,990 |
| 2024-02-13 | JOHNSON & JOHNSON | Decker Robert J
(VP Corporate Controller) |
M | Common Stock | A | 313 | $0.00 - $0.00 | $0 |
| 2024-02-13 | JOHNSON & JOHNSON | Decker Robert J
(VP Corporate Controller) |
F | Common Stock | D | 86 | $157.85 - $157.85 | $13,575 |
| 2024-02-12 | JOHNSON & JOHNSON | Broadhurst Vanessa
(EVP, Global Corp Affairs) |
M | Common Stock | A | 4701 | $0.00 - $0.00 | $0 |
| 2024-02-12 | JOHNSON & JOHNSON | Broadhurst Vanessa
(EVP, Global Corp Affairs) |
F | Common Stock | D | 2136 | $157.40 - $157.40 | $336,206 |
| 2024-02-12 | JOHNSON & JOHNSON | Broadhurst Vanessa
(EVP, Global Corp Affairs) |
A | Common Stock | A | 790 | $0.00 - $0.00 | $0 |
| 2024-02-12 | JOHNSON & JOHNSON | Hait William
(See Remarks) |
M | Common Stock | A | 8932 | $0.00 - $0.00 | $0 |
| 2024-02-12 | JOHNSON & JOHNSON | Hait William
(See Remarks) |
F | Common Stock | D | 4076 | $157.40 - $157.40 | $641,562 |
| 2024-02-12 | JOHNSON & JOHNSON | Wolk Joseph J
(Exec VP, CFO) |
M | Common Stock | A | 25835 | $0.00 - $0.00 | $0 |
| 2024-02-12 | JOHNSON & JOHNSON | Wolk Joseph J
(Exec VP, CFO) |
F | Common Stock | D | 10816 | $157.40 - $157.40 | $1,702,438 |
| 2024-02-12 | JOHNSON & JOHNSON | Forminard Elizabeth
(Executive VP, General Counsel) |
M | Common Stock | A | 2859 | $0.00 - $0.00 | $0 |
| 2024-02-12 | JOHNSON & JOHNSON | Forminard Elizabeth
(Executive VP, General Counsel) |
F | Common Stock | D | 1034 | $157.40 - $157.40 | $162,751 |
| 2024-02-12 | JOHNSON & JOHNSON | Taubert Jennifer L
(EVP, WWC. Innovative Medicine) |
M | Common Stock | A | 26202 | $0.00 - $0.00 | $0 |
| 2024-02-12 | JOHNSON & JOHNSON | Taubert Jennifer L
(EVP, WWC. Innovative Medicine) |
F | Common Stock | D | 13403 | $157.40 - $157.40 | $2,109,632 |
| 2024-02-12 | JOHNSON & JOHNSON | Fasolo Peter
(Exec VP, Chief HR Officer) |
M | Common Stock | A | 14960 | $0.00 - $0.00 | $0 |
| 2024-02-12 | JOHNSON & JOHNSON | Fasolo Peter
(Exec VP, Chief HR Officer) |
F | Common Stock | D | 7019 | $157.40 - $157.40 | $1,104,790 |
| 2024-02-12 | JOHNSON & JOHNSON | Swanson James D.
(EVP, CIO) |
M | Common Stock | A | 5456 | $0.00 - $0.00 | $0 |
| 2024-02-12 | JOHNSON & JOHNSON | Swanson James D.
(EVP, CIO) |
F | Common Stock | D | 1695 | $157.40 - $157.40 | $266,793 |
| 2024-02-12 | JOHNSON & JOHNSON | Duato Joaquin
(CEO and Chairman of the Board) |
M | Common Stock | A | 36618 | $0.00 - $0.00 | $0 |
| 2024-02-12 | JOHNSON & JOHNSON | Duato Joaquin
(CEO and Chairman of the Board) |
F | Common Stock | D | 15900 | $157.40 - $157.40 | $2,502,660 |
| 2024-02-12 | JOHNSON & JOHNSON | Schmid Timothy
(EVP, WW Chair, MedTech) |
M | Common Stock | A | 5736 | $0.00 - $0.00 | $0 |
| 2024-02-12 | JOHNSON & JOHNSON | Schmid Timothy
(EVP, WW Chair, MedTech) |
F | Common Stock | D | 2887 | $157.40 - $157.40 | $454,413 |
| 2024-02-12 | JOHNSON & JOHNSON | Decker Robert J
(VP Corporate Controller) |
M | Common Stock | A | 1912 | $0.00 - $0.00 | $0 |
| 2024-02-12 | JOHNSON & JOHNSON | Decker Robert J
(VP Corporate Controller) |
F | Common Stock | D | 523 | $157.40 - $157.40 | $82,320 |
| 2024-02-12 | JOHNSON & JOHNSON | Wengel Kathryn E
(EVP, Chief TO and Risk Officer) |
M | Common Stock | A | 13813 | $0.00 - $0.00 | $0 |
| 2024-02-12 | JOHNSON & JOHNSON | Wengel Kathryn E
(EVP, Chief TO and Risk Officer) |
F | Common Stock | D | 7066 | $157.40 - $157.40 | $1,112,188 |
| 2024-02-09 | JOHNSON & JOHNSON | Taubert Jennifer L
(EVP, WW Chair, Pharmaceuticals) |
S | Common Stock | D | 59397 | $156.27 - $156.27 | $9,281,969 |
| 2024-02-08 | JOHNSON & JOHNSON | Taubert Jennifer L
(EVP, WW Chair, Pharmaceuticals) |
M | Common Stock | A | 63136 | $0.00 - $90.44 | $5,371,864 |
| 2024-02-08 | JOHNSON & JOHNSON | Taubert Jennifer L
(EVP, WW Chair, Pharmaceuticals) |
F | Common Stock | D | 1913 | $156.33 - $156.33 | $299,059 |
| 2024-02-08 | JOHNSON & JOHNSON | Duato Joaquin
(CEO and Chairman of the Board) |
M | Common Stock | A | 5225 | $0.00 - $0.00 | $0 |
| 2024-02-08 | JOHNSON & JOHNSON | Duato Joaquin
(CEO and Chairman of the Board) |
F | Common Stock | D | 2269 | $156.33 - $156.33 | $354,712 |
| 2024-02-08 | JOHNSON & JOHNSON | Wengel Kathryn E
(EVP, Chief TO and Risk Officer) |
M | Common Stock | A | 1971 | $0.00 - $0.00 | $0 |
| 2024-02-08 | JOHNSON & JOHNSON | Wengel Kathryn E
(EVP, Chief TO and Risk Officer) |
F | Common Stock | D | 1009 | $156.33 - $156.33 | $157,736 |
| 2024-02-08 | JOHNSON & JOHNSON | Wolk Joseph J
(Exec VP, CFO) |
M | Common Stock | A | 3686 | $0.00 - $0.00 | $0 |
| 2024-02-08 | JOHNSON & JOHNSON | Wolk Joseph J
(Exec VP, CFO) |
F | Common Stock | D | 1047 | $156.33 - $156.33 | $163,677 |
| 2024-02-08 | JOHNSON & JOHNSON | Forminard Elizabeth
(Executive VP, General Counsel) |
M | Common Stock | A | 979 | $0.00 - $0.00 | $0 |
| 2024-02-08 | JOHNSON & JOHNSON | Forminard Elizabeth
(Executive VP, General Counsel) |
F | Common Stock | D | 363 | $156.33 - $156.33 | $56,747 |
| 2024-02-08 | JOHNSON & JOHNSON | Swanson James D.
(See Remarks) |
M | Common Stock | A | 1868 | $0.00 - $0.00 | $0 |
| 2024-02-08 | JOHNSON & JOHNSON | Swanson James D.
(See Remarks) |
F | Common Stock | D | 554 | $156.33 - $156.33 | $86,606 |
| 2024-02-08 | JOHNSON & JOHNSON | Schmid Timothy
(EVP, WW Chair, MedTech) |
M | Common Stock | A | 1964 | $0.00 - $0.00 | $0 |
| 2024-02-08 | JOHNSON & JOHNSON | Schmid Timothy
(EVP, WW Chair, MedTech) |
F | Common Stock | D | 1001 | $156.33 - $156.33 | $156,486 |
| 2024-02-08 | JOHNSON & JOHNSON | Fasolo Peter
(Exec VP, Chief HR Officer) |
M | Common Stock | A | 2135 | $0.00 - $0.00 | $0 |
| 2024-02-08 | JOHNSON & JOHNSON | Fasolo Peter
(Exec VP, Chief HR Officer) |
F | Common Stock | D | 781 | $156.33 - $156.33 | $122,093 |
| 2024-02-08 | JOHNSON & JOHNSON | Hait William
(See Remarks) |
M | Common Stock | A | 3059 | $0.00 - $0.00 | $0 |
| 2024-02-08 | JOHNSON & JOHNSON | Hait William
(See Remarks) |
F | Common Stock | D | 1113 | $156.33 - $156.33 | $173,995 |
| 2024-02-08 | JOHNSON & JOHNSON | Broadhurst Vanessa
(EVP, Global Corp Affairs) |
M | Common Stock | A | 1880 | $0.00 - $0.00 | $0 |
| 2024-02-08 | JOHNSON & JOHNSON | Broadhurst Vanessa
(EVP, Global Corp Affairs) |
F | Common Stock | D | 703 | $156.33 - $156.33 | $109,899 |
| 2024-02-08 | JOHNSON & JOHNSON | Decker Robert J
(VP Corporate Controller) |
M | Common Stock | A | 655 | $0.00 - $0.00 | $0 |
| 2024-02-08 | JOHNSON & JOHNSON | Decker Robert J
(VP Corporate Controller) |
F | Common Stock | D | 215 | $156.33 - $156.33 | $33,610 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |